Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission

Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission

Background Approximately 40% of adults with Philadelphia chromosome-negative acute lymphoblastic leukemia achieve long-term survival following unrelated donor hematopoietic stem cell transplantation in first complete remission but severe graft-versus-host disease remains a problem affecting survival...

Full description

Bibliographic Details
Main Authors: Bella Patel, Keiren E. Kirkland, Richard Szydlo, Rachel M. Pearce, Richard E. Clark, Charles Craddock, Effie Liakopoulou, Adele K. Fielding, Stephen Mackinnon, Eduardo Olavarria, Mike N. Potter, Nigel H. Russell, Bronwen E. Shaw, Gordon Cook, Anthony H. Goldstone, David I. Marks
Format: Article
Language:English
Published: Ferrata Storti Foundation 2009-10-01
Series:Haematologica
Online Access:https://haematologica.org/article/view/5376

Internet

https://haematologica.org/article/view/5376

Similar Items